Delivery Order SPE2DB22D1106-SPE2DB24FEMN1
Award Date 4/19/24
Potential Completion Date 4/22/24
Potential Value $6.6K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,566,177,428 units of Ondansetron ODT 8 mg tablets. The $4,191.53 Firm Fixed Price Delivery Order was issued by the Defense Logistics Agency (DLA) on October 22, 2024, with a completion date of October 23, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award to Amerisourcebergen Drug Corp is for the delivery of 4,564,943,555 units of the pharmaceutical drug Ondansetron ODT 4 mg tablets. The $24,544.20 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract has an ultimate completion date of June 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,298,868 units of the pharmaceutical product Ondansetron ODT 4 mg Tablet 30s. The $3,125.70 Firm Fixed Price Delivery Order was awarded by the Defense Logistics Agency (DLA), a defense agency, on April 16, 2024 with a completion date of April 17, 2024. This contract is not designated as a set-aside. Amerisourcebergen, a major supplier of pharmaceutical products and medical...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of 4,564,817,027 units of the pharmaceutical product Ondansetron ODT 8 mg Tablet in 30-count packages. The contract has a ceiling value of $6,154.92 and is a delivery order with a firm fixed price. The contracting agency is the Defense Logistics Agency (DLA) Troop Support Medical, which provides logistics and acquisition services for the U.S. Department of Defense. Amerisourcebergen...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide 4,564,792,670 units of the medication Ondansetron ODT 4 mg Tablet 30s. The $11,305.60 Firm Fixed Price Delivery Order has a completion date of June 4, 2024 and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation, is for the delivery of 4564389589 Ondansetron ODT 4 MG Tablet 30S. The $2,360.32 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, the medical supply chain division of the Department of Defense (DoD), and has an ultimate completion date of April 25, 2024. Amerisourcebergen, one of the largest pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,008,244 units of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $11,330.40 firm fixed price delivery order has a June 27, 2024 completion date. As a subsidiary of one of the largest pharmaceutical distributors, Amerisourcebergen leverages its extensive supply chain to fulfill government contracts, with a focus on serving the Department of Defense (DoD)...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation, is for the delivery of 4,565,047,457 units of the prescription medication Ondansetron ODT 4 mg tablets. The $1,251.66 firm fixed-price contract was awarded on July 1, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 2, 2024. This appears to be a delivery order under...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,528.76 contract is for the supply of 4,564,885,759 units of the pharmaceutical product Ondansetron ODT 4 mg tablets, with an ultimate completion date of June 13, 2024. Amerisourcebergen, a large pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of 4564943680 units of 30-count Ondansetron ODT 4 mg tablets. The contract has a ceiling value of $12,201.16 and was awarded by the Defense Logistics Agency, a component of the Department of Defense, as a Firm Fixed Price Delivery Order. The award does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00...